|11.64|| -0.38 / -3.16%|
Sagent Pharmaceuticals, Inc. is a pharmaceutical company, which focuses on developing, manufacturing, sourcing and marketing pharmaceutical products. Its primary focus on generic injectable pharmaceuticals, which provide customers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes and premix bags. The company operates through following segments: Sagent U.S. and Omega. The Sagent U.S. segment consists of U.S. operations and the SCP manufacturing facility. The Omega segment focuses on the Canadian and international markets. Sagent Pharmaceuticals was founded by Jeffrey M. Yordon on January 26, 2006 and is headquartered in Schaumburg, IL.
|Allan Oberman||Chief Executive Officer & Director|
|J. Frank Harmon||Executive Vice President-Global Operations|
|Jonathon M. Singer||Chief Financial Officer & Executive Vice President|
|Jeffrey W. Greve||Vice President & Controller|
|Sean Brynjelsen||Executive Vice President-Business Development|